| Indivior Schweiz AG - Suboxone 8 mg/2 mg, Sublingualtabletten | | 58405 | | 02 | | Suboxone 8 mg/2 mg | | Sublingualtabletten | | N07BC51 | | Buprenorphine, combinations | | 25.02.2009 | | |
| | Composition | | buprenorphinum 8 mg ut buprenorphini hydrochloridum, naloxonum 2 mg ut naloxoni hydrochloridum dihydricum, lactosum monohydricum corresp. lactosum 167.5 mg, mannitolum, maydis amylum, povidonum K 30, acidum citricum, natrii citras dihydricus corresp. natrium 0.24 mg, aromatica (Zitrone und Limette) cum linaloolum et citralum et E 320, acesulfamum kalicum, magnesii stearas, pro compresso. | | Packungsbestandteile | | Comprimés sublinguaux | | | | | Principe actif | Concentr. |
|---|
| Buprenorphine | 8 mg | | Naloxone | 2 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Buprenorphine | 8 mg | | Naloxone | 2 mg |
| | | | Agents auxilliaires | Concentr. |
|---|
| Acesulfamum Kalicum | | | Acide Citrique | | | Aromatica (Zitrone und Limette) cum Linaloolum | | | Citral | | | E 320 | | | Lactose Monohydrate | | | Magnesii Stearas | | | Mannitol | | | Maydis Amylum | | | Natrii Citras Dihydricus | | | Povidonum K | 30 | | Pro Compresso | |
| |
| |
|
